Alcohol Cue Reactivity for Alcohol Consumption
(MIND Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to understand how the brain and body react to images of alcohol compared to water. Researchers seek to learn how these reactions relate to drinking habits, potentially aiding in the development of new treatments for Alcohol Use Disorders. Participants will undergo MRI scans, blood tests, and an Alcohol Taste Test as part of the Alcohol Cue Reactivity and Laboratory Alcohol Administration Paradigm. The trial seeks regular beer drinkers aged 21-25, including those who binge drink and those who drink socially without bingeing. As an unphased trial, this study offers participants the chance to contribute to groundbreaking research that could lead to innovative treatments for Alcohol Use Disorders.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, you must pass a toxicology screening for substances at all study appointments, which might affect certain medications.
What prior data suggests that this protocol is safe for participants?
Studies have shown that participating in the Alcohol Cue Reactivity and Laboratory Alcohol Administration Paradigm is generally safe. Research indicates that these lab settings often study reactions to alcohol-related cues, like pictures of alcohol. These studies help researchers understand behaviors related to alcohol use.
Participants in these studies view alcohol-related images and sometimes consume small, controlled amounts of alcohol. The goal is to measure bodily and brain responses. This method is well-tolerated, with most participants not experiencing serious side effects. However, some may feel mild discomfort, such as anxiety or cravings, but these effects are temporary and manageable.
The research focuses on understanding reactions to alcohol cues, not on developing a new treatment. Therefore, the risks are low and mainly involve normal responses to seeing or thinking about alcohol.12345Why are researchers excited about this trial?
Researchers are excited about the Alcohol Cue Reactivity and Laboratory Alcohol Administration Paradigm because it offers a new way to understand and potentially reduce alcohol consumption. Unlike standard treatments that often focus on medication or therapy alone, this approach uses behavioral interventions to directly expose participants to alcohol cues in a controlled setting. By studying how people react to these cues, scientists hope to uncover the psychological and physiological triggers of binge and social drinking. This could lead to more personalized and effective strategies for managing alcohol use, offering a fresh perspective beyond the typical focus on abstinence or medication.
What evidence suggests that this trial's treatments could be effective for understanding alcohol use behaviors?
This trial will compare how the brains of binge drinkers and social drinkers react to alcohol-related images. Research has shown that the brain's response to such images can predict drinking habits. Studies have found that alcohol-related images trigger more activity in brain areas associated with reward and craving than neutral images. This method helps researchers understand how the brain processes alcohol and may explain why some people drink more. Other research suggests this approach can help test new treatments for Alcohol Use Disorders by serving as an early indicator of their effectiveness. Understanding these brain responses might lead to better ways to manage or treat drinking problems.12456
Are You a Good Fit for This Trial?
This trial is for healthy individuals who regularly drink alcohol. They should be willing to undergo MRI scans, blood draws, and participate in an Alcohol Taste Test involving beer consumption. Participants are required to complete psychological questionnaires and multiple surveys on a smartphone over the course of three years.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete psychological questionnaires and undergo MRI scans with blood draws. Alcohol Taste Test is conducted after each MRI scan.
1-Year Follow-up
Participants undergo MRI scans with blood draws and Alcohol Taste Test. EMA surveys conducted for 21 days.
2-Year Follow-up
Participants undergo MRI scans with blood draws and Alcohol Taste Test. EMA surveys conducted for 21 days.
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Alcohol Cue Reactivity and Laboratory Alcohol Administration Paradigm
Find a Clinic Near You
Who Is Running the Clinical Trial?
Auburn University
Lead Sponsor